188 related articles for article (PubMed ID: 24714525)
1. Sickle cell disease in India.
Colah R; Mukherjee M; Ghosh K
Curr Opin Hematol; 2014 May; 21(3):215-23. PubMed ID: 24714525
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.
Italia Y; Krishnamurti L; Mehta V; Raicha B; Italia K; Mehta P; Ghosh K; Colah R
J Med Screen; 2015 Mar; 22(1):1-7. PubMed ID: 25341880
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening shows a high incidence of sickle cell anemia in Central India.
Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
7. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
[TBL] [Abstract][Full Text] [Related]
8. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Okam MM; Ebert BL
Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease in tribal populations in India.
Colah RB; Mukherjee MB; Martin S; Ghosh K
Indian J Med Res; 2015 May; 141(5):509-15. PubMed ID: 26139766
[TBL] [Abstract][Full Text] [Related]
10. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India.
Labie D; Srinivas R; Dunda O; Dode C; Lapoumeroulie C; Devi V; Devi S; Ramasami K; Elion J; Ducrocq R
Hum Biol; 1989 Aug; 61(4):479-91. PubMed ID: 2480325
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India.
Nimgaonkar V; Krishnamurti L; Prabhakar H; Menon N
Pediatr Blood Cancer; 2014 Apr; 61(4):702-5. PubMed ID: 24347362
[TBL] [Abstract][Full Text] [Related]
12. Sickle cell disease treatment and management in India: a systematic review of interventional studies.
Sridevi P; Sharma Y; Balakrishna SL; Babu BV
Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1101-1111. PubMed ID: 36227060
[TBL] [Abstract][Full Text] [Related]
13. Sickle Cell Disease in Central India: A Potentially Severe Syndrome.
Jain D; Warthe V; Dayama P; Sarate D; Colah R; Mehta P; Serjeant G
Indian J Pediatr; 2016 Oct; 83(10):1071-6. PubMed ID: 27053181
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of sickle cell disease in India: misconceptions and reality.
Jain D; Mohanty D
Curr Opin Hematol; 2018 May; 25(3):171-176. PubMed ID: 29465435
[TBL] [Abstract][Full Text] [Related]
15. Maternal and perinatal outcome of women with sickle cell disease of a tribal population in Central India.
Natu N; Khandelwal S; Kumar R; Dave A
Hemoglobin; 2014; 38(2):91-4. PubMed ID: 24417305
[TBL] [Abstract][Full Text] [Related]
16. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
Lebensburger J; Johnson SM; Askenazi DJ; Rozario NL; Howard TH; Hilliard LM
Am J Hematol; 2011 May; 86(5):430-2. PubMed ID: 21523807
[TBL] [Abstract][Full Text] [Related]
17. Characterization of S-glutathionyl hemoglobin in homozygous sickle cell disease.
Thom GG; Kallanagowdar C; Somjee SS; Velez MC; Yu LC; Hempe JM
J Pediatr Hematol Oncol; 2009 Dec; 31(12):895-900. PubMed ID: 19855306
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.
Colah R; Surve R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Satoskar P; Mohanty D
Prenat Diagn; 2005 May; 25(5):345-9. PubMed ID: 15906420
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease; a general overview.
Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
[TBL] [Abstract][Full Text] [Related]
20. Newborn Screening for Sickle Cell Disease Among Tribal Populations in the States of Gujarat and Madhya Pradesh in India: Evaluation and Outcome Over 6 Years.
Thaker P; Colah RB; Patel J; Raicha B; Mistry A; Mehta V; Italia Y; Desai S; Dave K; Shanmugam R; Ghosh K; Mukherjee MB
Front Med (Lausanne); 2021; 8():731884. PubMed ID: 35242766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
